These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28768917)

  • 21. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
    Krum H; van Veldhuisen DJ; Funck-Brentano C; Vanoli E; Silke B; Erdmann E; Follath F; Ponikowski P; Goulder M; Meyer W; Lechat P; Willenheimer R;
    Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
    Toda H; Nakamura K; Shimizu K; Ejiri K; Iwano T; Miyoshi T; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Hikasa Y; Hayashi M; Morita H; Morimatsu H; Ito H;
    Circ J; 2020 Mar; 84(4):642-649. PubMed ID: 32092717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
    Dobre D; van Veldhuisen DJ; Goulder MA; Krum H; Willenheimer R
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):399-405. PubMed ID: 18528751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal patch of bisoprolol for the treatment of hypertension complicated with aortic dissection.
    Hara T; Yagi S; Akaike M; Sata M
    Int J Cardiol; 2015 Nov; 198():220-1. PubMed ID: 26173061
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].
    Babushkina GV; Shaikhlislamova GI
    Kardiologiia; 2020 Oct; 60(10):33-37. PubMed ID: 33228503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisoprolol and heart failure: new frontiers.
    Chopra HK
    Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure.
    Toyoda S; Haruyama A; Inami S; Amano H; Arikawa T; Sakuma M; Abe S; Tanaka A; Node K; Inoue T
    Int J Cardiol; 2017 Jan; 226():71-76. PubMed ID: 27792991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].
    Kanorsky SG; Borisenko YV
    Kardiologiia; 2016 Feb; 56(2):24-29. PubMed ID: 28294745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
    Wang F; Xu ZM; Wang L; Bian WY; Jia X; Duan B; Li W; Li YS
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):490-4. PubMed ID: 16080835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches.
    Sezai A; Sekino H; Taoka M; Osaka S; Tanaka M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
    Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
    Yamamoto K; Yamada T; Hamuro M; Kawatou M; Enomoto S
    Kyobu Geka; 2017 Nov; 70(12):971-977. PubMed ID: 29104194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients.
    Yasui T; Oka T; Shioyama W; Oboshi M; Fujita M
    SAGE Open Med; 2020; 8():2050312120907817. PubMed ID: 32128207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.